Biomarker Strategies, LLC

Derwood, MD 20855

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.81MM
First Award Date 09/23/15
Most Recent Award Date 09/22/17

Key Personnel

Last Name Name Awards Contact
BERTENSHAW GREG BERTENSHAW 4

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/22/17 - 06/30/18

ABSTRACT Head and neck squamous cell carcinoma (HNSCC) is the world?s 6th leading cause of cancer, accounting for 5% of cancer mortality. For many other cancers, molecular characterization has led to sub-classification of disease based on the status of oncogenic drivers in signal transduction pathways, leading to the development of molecularly-t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/01/17 - 08/31/18

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/19/16 - 06/18/17

Significant advances in the development of immune checkpoint inhibitors have yielded durable responses in Non-Small Cell Lung Cancer (NSCLC), the most common form of lung cancer. Unfortunately, many patients who might ultimately respond to this important therapy may not receive it because they are considered biomarker negative by today?s Compani...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/23/15 - 02/29/16

DESCRIPTION (provided by applicant): Lung cancer (LC) is the leading cause of cancer death in the US with an estimated 158,040 deaths in 2015. Non- small cell LC is the predominant category of the disease (NSCLC;83%). Molecular characterization of tumors has shifted the paradigm of one drug fits all. Currently, molecularly-targeted agents (MTAs)...